Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Analysts and Calls -- C.E. Unterberg, Towbin -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (2)	12/1/2002 3:47:37 PM
From: Icebrg	Read Replies (1) \| Respond to of 8

ICOS Corporation November , 25 , 2002 , 00:00 : We are raising our 12-month price target from $28 to $43 to factor in the full potential of Cialis, which we expect can achieve more than $1 billion in sales in 2006. With pharmaceutical sector maintaining the recovery in price to sales multiples since the lows set in late-July, we are also raising the price to sales ratio used in our valuation (see Valuation.) We reiterate our Short- and Long-Term Buy ratings.